Renergen (ASX: RLT) creates vaccine storage solution

Renergen (ASX: RLT) creates vaccine storage solution

Energy, Health Care

ASX:RLT MCAP $157.3M

· Helium and natural gas producer Renergen (RLT) has created a vaccine storage solution which effectively simplifies the process of transferring immunisations

· Renergen Cryo-Vacc allows vaccines to be stored in extremely cold temperatures for 30 days without the need for a power supply

· The storage contains liquid helium, which is able to be boiled and released consistently for a month — providing the cold tempertaure

· The company has described the solution as ground breaking and has filed for patent rights on the device

· RLT is also calling on collaborators to use the design, to assist in the deployment of vaccines such as Pfizer's COVID-19 jab

· Shares in RLT have opened today trading up 6.72 per cent to trade at $1.43 each

Renergen (RLT) has created a new vaccine storage solution which effectively simplifies the process of transferring immunisations.

The invention by the helium and natural gas producer comes at a key time, as Pfizer and other drug makers begin rolling out their COVID-19 vaccines.

Read the full release here: https://themarketherald.com.au/renergen-asxrlt-creates-vaccine-storage-solution-2020-12-10/